Try it
ENT · Larynx and airway: adjuvant therapy for papillomatosis
Sample itemA child with aggressive recurrent respiratory papillomatosis needs repeated surgery more than 4 times per year and has lung involvement. Which adjuvant drug has been used to reduce recurrence?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Bevacizumab, an anti-VEGF antibody
Intralesional or systemic bevacizumab and cidofovir are adjuvants in aggressive recurrent respiratory papillomatosis, aimed at reducing the frequency of surgery. HPV vaccination reduces incidence. Tracheostomy should be avoided, as it may seed the lower airway.
Option by option
A. Amphotericin B
Amphotericin treats fungal infection.
B. Methotrexate
Methotrexate is not an accepted therapy.
C. Isoniazid
Isoniazid treats tuberculosis.
D. Bevacizumab, an anti-VEGF antibody (correct)
Correct. Anti-VEGF therapy has been used successfully.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More ENT questions
- AudiologyIn a tuning fork test, Rinne is negative (bone conduction louder than air conduction) in…
- EarWhich type of chronic suppurative otitis media is considered 'unsafe'?
- LarynxIn singers, vocal nodules typically occur at:
- Vestibular disordersA patient has recurrent attacks of vertigo lasting hours, with fluctuating low-frequency…